Intrinsic Value of S&P & Nasdaq Contact Us

Citius Pharmaceuticals, Inc. CTXR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
33/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CTXR

Citius Pharmaceuticals, Inc. (CTXR) has a market capitalization of $9.57M and trades at $0.86. The 52-week range is 0.63-2.48.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-3.38.

The stock has a beta of 1.38, operates in the Healthcare sector.

Trading Data
Current Price$0.86
52-Week Range0.63-2.48
Volume314.07K
Avg Volume (30D)561.51K
Market Cap$9.57M
Beta (1Y)1.38
Company
IPO Date2014-10-02
Employees23
CEOLeonard L. Mazur
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS17322U3068
CUSIP17322U207
Income (Latest Year)
Gross Profit$-214.25K
EBITDA$-38.2M
Operating Income$-38.53M
Net Income$-37.43M
EPS$-3.38
EPS Diluted$-3.38
Shares Outstanding$11.07M
Balance Sheet (Latest Year)
Total Assets$130.94M
Current Assets$27.93M
Cash & ST Investments$4.25M
Total Liabilities$53.41M
Total Debt$1.81M
Net Debt$-2.44M
Total Equity$77.53M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-0.3
P/B Ratio0.12
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message